Prevalence of Disease and Relationships between Laboratory Phenotype and Bleeding Severity in Platelet Primary Secretion Defects

Abstract

BackgroundThe prevalence of platelet primary secretion defects (PSD) among patients with bleeding diathesis is unknown. Moreover, there is paucity of data on the determinants of bleeding severity in PSD patients.ObjectiveTo determine the prevalence of PSD in patients with clinical bleeding and to study the relationships between the type of platelet defect and bleeding severity.MethodsData on patients referred for bleeding to the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan (Italy) in the years between 2008 and 2012 were retrieved to study the prevalence of PSD. Demographic, clinical and laboratory information on 32 patients with a diagnosis of PSD was used to compare patients with or without associated medical conditions and to investigate whether or not the type and extension of platelet defects were associated with the bleeding severity score (crude and age-normalized) or with the age at first bleeding requiring medical attention.ResultsThe estimated prevalence of PSD among 207 patients with bleeding diathesis and bleeding severity score above 4 was 18.8% (95% confidence interval [CI]: 14.1–24.7%). Patients without associated medical conditions had earlier age of first bleeding (18 vs 45 years; difference: -27 years; 95% CI: -46 to -9 years) and different platelet functional defect patterns (Fisher's exact test of the distribution of patterns, P = 0.007) than patients with accompanying medical conditions. The type and extension of platelet defect was not associated with the severity of bleeding.ConclusionsPSD is found in approximately one fifth of patients with clinical bleeding. In patients with PSD, the type and extension of laboratory defect was not associated with bleeding severity.

Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder

“…The main goal of our present study was to assess the reproducibility of lumi‐aggregometry assessments of platelet dense granule ATP release, performed with multiple agonists, as a diagnostic test for platelet function disorders. The important issue of the test reproducibility in patients had not been addressed by earlier and recent reports on dense granule ATP release findings for patients . Furthermore, guidelines are lacking on how to deal with the high degree of intra‐ and intertest variability of dense granule ATP release when performing and reporting results for patients.…”

Hemostatic Abnormalities in Noonan Syndrome

“…19 Finally, in a large cohort of adults investigated in our center for a suspected abnormality of primary hemostasis, no correlation between platelet function abnormalities and the bleeding score was observed. 20 …”

Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research

“…In contrast to severe PFDs (i.e. Glanzmann thrombasthenia and Bernard–Soulier syndrome), no correlation exists between bleeding severity and extent of laboratory abnormalities . The effect of aspirin on platelet aggregation/secretion in non‐bleeder healthy subjects illustrates this point, as the drug‐induced laboratory defects are usually more remarkable than those observed in most inherited PFDs (Fig.…”